A cutting-edge, dual-action injectable medication Combining GLP-1 and GIP receptor agonists to improve metabolic health and aid in weight loss
Combining GLP-1 and GIP receptor agonists to improve metabolic health and aid in weight loss
How It Works:
- Dual receptor activation: Stimulates GLP-1 and GIP receptors to improve insulin secretion and decrease insulin resistance.
- Appetite regulation: Slows digestion and reduces hunger by signaling satiety to the brain.
- Blood sugar management: Lowers post-meal glucose spikes and stabilizes blood sugar levels.
Who is not eligible:
- Individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
- Those with severe gastrointestinal conditions or pancreatitis.
- Pregnant or breastfeeding individuals.
- This is not an exhaustive list of side effects or eligibility criteria.
More detailed information will be provided during your consultation.
